Literature DB >> 23352817

Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies.

Vishal G Patel1, Kimberly M Brayton, Aracely Tamayo, Owen Mogabgab, Tesfaldet T Michael, Nathan Lo, Mohammed Alomar, Deborah Shorrock, Daisha Cipher, Shuaib Abdullah, Subhash Banerjee, Emmanouil S Brilakis.   

Abstract

OBJECTIVES: This study sought to perform a weighted meta-analysis of the complication risk during chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
BACKGROUND: The safety profile of CTO PCI has received limited study.
METHODS: We conducted a meta-analysis of 65 studies published between 2000 and 2011 reporting procedural complications of CTO PCI. Data on the frequency of death, emergent coronary artery bypass graft surgery, stroke, myocardial infarction, perforation, tamponade, stent thrombosis, major vascular or bleeding events, contrast nephropathy, and radiation skin injury were collected.
RESULTS: A total of 65 studies with 18,061 patients and 18,941 target CTO vessels were included. Pooled estimates of outcomes were as follows: angiographic success 77% (95% confidence interval [CI]: 74.3% to 79.6%); death 0.2% (95% CI: 0.1% to 0.3%); emergent coronary artery bypass graft surgery 0.1% (95% CI: 0.0% to 0.2%); stroke <0.01% (95% CI: 0.0% to 0.1%); myocardial infarction 2.5% (95% CI: 1.9% to 3.0%); Q-wave myocardial infarction 0.2% (95% CI: 0.1% to 0.3%); coronary perforation 2.9% (95% CI: 2.2% to 3.6%); tamponade 0.3% (95% CI: 0.2% to 0.5%); and contrast nephropathy 3.8% (95% CI: 2.4% to 5.3%). Compared with successful procedures, unsuccessful procedures had higher rates of death (0.42% vs. 1.54%, p < 0.0001), perforation (3.65% vs. 10.70%, p < 0.0001), and tamponade (0% vs. 1.65%, p < 0.0001). Among 886 lesions treated with the retrograde approach, success rate was 79.8% with no deaths and low rates of emergent coronary artery bypass graft surgery (0.17%) and tamponade (1.2%).
CONCLUSIONS: CTO PCI carries low risk for procedural complications despite high success rates.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23352817     DOI: 10.1016/j.jcin.2012.10.011

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  76 in total

1.  The impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcomes.

Authors:  Georgios E Christakopoulos; Muhammad Nauman J Tarar; Emmanouil S Brilakis
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

2.  Temporal trends of fluoroscopy time and contrast utilization in coronary chronic total occlusion revascularization: insights from a multicenter United States registry.

Authors:  Tesfaldet T Michael; Dimitri Karmpaliotis; Emmanouil S Brilakis; Mohammed Alomar; Shuaib M Abdullah; Ben L Kirkland; Katrina L Mishoe; Nicholas Lembo; Anna Kalynych; Harold Carlson; Subhash Banerjee; Michael Luna; William Lombardi; David E Kandzari
Journal:  Catheter Cardiovasc Interv       Date:  2014-01-31       Impact factor: 2.692

3.  Complete versus incomplete coronary revascularization of patients with multivessel coronary artery disease.

Authors:  Yader Sandoval; Emmanouil S Brilakis; Mariana Canoniero; Demetris Yannopoulos; Santiago Garcia
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

Review 4.  Common and Uncommon CTO Complications.

Authors:  Johannes Rigger; Colm G Hanratty; Simon J Walsh
Journal:  Interv Cardiol       Date:  2018-09

5.  What the surgeon needs to know about percutaneous coronary intervention treatment of chronic total occlusions.

Authors:  Satoru Mitomo; Ozan M Demir; Antonio Colombo; Sunao Nakamura; Alaide Chieffo
Journal:  Ann Cardiothorac Surg       Date:  2018-07

Review 6.  Update on the Management of Chronic Total Occlusions in Coronary Artery Disease.

Authors:  Kathleen Kearney; Ravi S Hira; Robert F Riley; Arun Kalyanasundaram; William L Lombardi
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

7.  Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry.

Authors:  Georgios Christopoulos; Dimitri Karmpaliotis; Khaldoon Alaswad; Robert W Yeh; Farouc A Jaffer; R Michael Wyman; William L Lombardi; Rohan V Menon; J Aaron Grantham; David E Kandzari; Nicholas Lembo; Jeffrey W Moses; Ajay J Kirtane; Manish Parikh; Philip Green; Matthew Finn; Santiago Garcia; Anthony Doing; Mitul Patel; John Bahadorani; Muhammad Nauman J Tarar; Georgios E Christakopoulos; Craig A Thompson; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Int J Cardiol       Date:  2015-06-27       Impact factor: 4.164

Review 8.  Advances in the management of coronary chronic total occlusions.

Authors:  Emmanouil S Brilakis; Dimitri Karmpaliotis; Minh N Vo; Santiago Garcia; Lampros Michalis; Khaldoon Alaswad; Parag Doshi; William L Lombardi; Subhash Banerjee
Journal:  J Cardiovasc Transl Res       Date:  2014-03-15       Impact factor: 4.132

Review 9.  Frequency and outcomes of aortocoronary dissection during percutaneous coronary intervention of chronic total occlusions: a case series and systematic review of the literature.

Authors:  Deborah Shorrock; Tesfaldet T Michael; Vishal Patel; Anna Kotsia; Bavana V Rangan; Shuaib A Abdullah; Jerrold M Grodin; Avantika Banerjee; Emmanouil S Brilakis
Journal:  Catheter Cardiovasc Interv       Date:  2013-12-23       Impact factor: 2.692

10.  A Novel Risk Score in Predicting Failure or Success for Antegrade Approach to Percutaneous Coronary Intervention of Chronic Total Occlusion: Antegrade CTO Score.

Authors:  Mohammad Hasan Namazi; Ali Reza Serati; Hosein Vakili; Morteza Safi; Saeed Ali Pour Parsa; Habibollah Saadat; Maryam Taherkhani; Sepideh Emami; Shamseddin Pedari; Masoomeh Vatanparast; Mohammad Reza Movahed
Journal:  Int J Angiol       Date:  2016-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.